Medpace Holdings, Inc. (MEDP): Share Repurchases

Annual figures by period end, from SEC filings.

$917.39M
Year ended 2025-12-31
$299.34M
Trailing 12 months to 2026-06-30
+2.7%
3-year compound annual growth
+56.3%
5-year compound annual growth
2015-12-31: $02016-12-31: $02017-12-31: $155.58M2018-12-31: $02019-12-31: $02020-12-31: $98.27M2021-12-31: $62.10M2022-12-31: $847.85M2023-12-31: $144.02M2024-12-31: $169.87M2025-12-31: $917.39M$917.39M
2015-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$917.39M+440.1%2026-02-10, From 2025-01-01
2024-12-31$169.87M+17.9%2026-02-10, From 2024-01-01
2023-12-31$144.02M-83.0%2026-02-10, From 2023-01-01
2022-12-31$847.85Mn/m2025-02-11, From 2022-01-01
2021-12-31$62.10M-36.8%2024-02-13, From 2021-01-01
2020-12-31$98.27Mn/a2023-02-14, From 2020-01-01
2019-12-31$0n/a2022-02-15, From 2019-01-01
2018-12-31$0-100.0%2021-02-16, From 2018-01-01
2017-12-31$155.58Mn/a2020-02-25, From 2017-01-01
2016-12-31$0n/a2019-02-26, From 2016-01-01
2015-12-31$0n/a2018-02-27, From 2015-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
Medpace Holdings, Inc. (MEDP)2025-12-31$917.39M+440.1%
Charles River Laboratories International, Inc. (CRL)2025-12-27$360.67M+202.6%
Incyte Corp (INCY)2025-12-31$0-100.0%
Icon PLC (ICLR)2025-12-31$750.00M+50.0%
Iqvia Holdings Inc. (IQV)2025-12-31$1.24B-7.9%
NRC Health (NRC)2025-12-31$20.18M-34.8%
IB Acquisition Corp. (IBAC)2025-09-30$106.13Mn/a

Compare MEDP, CRL, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗